latest news stock values companies glp-1 obesity cardiometabolic Outlook for in 2025: more than a transition year The metabolic health revolution has

Johnson B, et al

Bit of Background These new classes of antiobesity medications (ie, the GLP-1 agonists and dual agonists), referred to in this article as weight management medications, arent really new.1-4 The basic science and pharmaceutical research and development to bring these to market began more than two decades ago when two scientists, Matthias Tschop, MD, and Richard DiMarchi, PhD, hypothesized that the actions of various gut hormones may offer safe and unprecedented weight loss

18 Similarly, the claim-based frailty index was estimated from the administrative dataset using a previously validated methodology that incorporates Current Procedural Terminology (CPT) codes, Healthcare Common Procedure Coding System (HCPCS) codes, and ICD codes

Some people do better on one medication for mood stability, while others feel more irritable on that same option